FDA approves Alzheimer’s drug lecanemab amid security situations

June 12, 2023: On Friday, A panel of independent people to the Food and Drug Administration meeting to recommend whether the Alzheimer’s drug Leqembi, created by Eisai and Biogen, should receive full approval.

The FDA is not required to follow the advisor’s recommendation, but a panel vote in favor of Leqembi would help pave the way for the treatment’streatment’s support this summer.

The FDA is expected to decide on Leqembi on July 6. The agency’sagency’s decision will determine whether Medicare broadly covers the treatment. The program for seniors is severely restricting coverage of Leqembi right now because it was approved through an expedited process.

Leqembi is the second Alzheimer’s treatment from Eisai and Biogen to come under FDA review after the controversial approval of Aduhelm in the summer of 2021.

The drug regulator granted expedited approval to Aduhelm, developed by the two companies, despite 10 of 11 advisory committee members concluding that the treatment did not indicate a clinical benefit. A congressional investigation subsequently found that the approval of Aduhelm was life with irregularities.

Eisai’s study of Leqembi found the drug slowed cognitive decline in early Alzheimer’s patients by 27%. The antibody is administered twice monthly through intravenous infusion. It targets a protein called amyloid, often named plaque, that builds up in the brain and is associated with the disease.

Dr. Teresa Buracchio, acting head of the FDA’s neuroscience office, told the panel that the instrument views these results as clinically meaningful for patients.

But Leqembi also harbors severe risks of brain swelling and bleeding. During the study, 13% of patients who received Leqembi had swelling, and 14% had bleeding.

The swelling and bleeding are typically mild without apparent symptoms, but these episodes can stand life-threatening, according to the FDA.

Three deaths in the study were possibly related to Leqembi, though the FDA could not draw explicit conclusions in its review.

Two patients who died suffered cerebral hemorrhages after receiving the infusions. They had been administered blood thinner medications. A third patient who died had an underlying condition named cerebral amyloid angiopathy, in which the blood vessels in the brain are weak, which can lead to bleeding.

Dr. Deniz Erten-Lyons, an FDA official, told the committee that taking blood thinners during therapy with Leqembi might increase the risk of cerebral hemorrhages.

About Us

We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.

Recent Posts

CalFoods Logistics | Making A Difference for those in Need | Steve Linkhart

Steve Linkhart, CEO of CalFoods Logistics, believes that he possesses one quality that sets the tone for CalFoods Logistics. “When we hire a new team member, there are clear responsibilities that need to be accomplished. Once we hire, train, and let that person take the ownership of the job, we allow them to do their job,” he explains. “We are always there to assist of course, but I feel that people get a sense of ownership of their role when they are allowed to do so. Everyone has a role from being CEO to pulling or entering orders, everyone has their unique responsibilities, and the foundation is always customer service, without that, everything after is on shaky ground.” Steve feels that there isn’t a role here too big or too small for anyone to jump in and help. He has unloaded his fair share of trucks and pulled orders over the past 18 months and will be glad to do it again if needed. “Taking care of our team is of the utmost importance to me. We offer a living wage, amazing benefits, and time off for the team to have a good work/life balance.”

Innovana Solutions | Leading with Determination & Commitment | Mitch McDermid

When Mitch McDermid launched Innovana, he had an evident vision of what he wanted the company to look like and what it could offer that was different from existing IT services and consulting firms. There was a clear need for a cloud-based services and business automation solutions provider that would address the needs of SMBs both from a pricing and service standpoint in Canada. Mitch and his team have been laser-focused on serving that niche.

Arete Wealth | Offering Excellence & Virtue | Joshua D. Rogers

A forward thinker, Joshua D. Rogers is always focused on the future. His vision was to introduce a smart, sophisticated approach to investing and wealth building. Since founding Arete Wealth in 2007, he’s done just that. Joshua’s brought an endowment-style of asset allocation to a broader audience of investors. From hedge funds to bespoke investments, his dream was to bring a new perspective to investing. Arete Wealth is the embodiment of that vision: a dynamic, energetic, comprehensive wealth management firm focused on the future.

OnView Integrated Solutions | The Guardian Angel | Joel Anaya

Joel Anaya, CEO of OnView Integrated Solutions, has been instrumental in building the company from the ground up. His innovation and vision transformed the way the company has scaled its business. OnView is a security provider bringing proactive solutions specifically designed to deter suspicious behavior in real-time before the crime occurs.

Western Development Museum | Creating Health, Happiness & Community Cohesion | Joan Kanigan

Joan Kanigan, CEO of the Western Development Museum (WDM), took an extraordinarily unique yet bold step as a leader in 2021. She initiated a 360o Performance Assessment to better understand how she was performing and where she needed to improve—all through an honest and critical feedback system to know where she was standing as a leader and a manager. “My intent with this performance review was to ensure I am serving the WDM and those I am responsible for to the best of my abilities,” she says. “The things that my staff felt I was doing most effectively include listening to them at all levels, using staff input to make decisions; making people comfortable to bring issues, opinions, and questions forward; valuing others’ thoughts and opinions; and identifying needs and opportunities for organizational improvement.”

Jacobs & Cushman San Diego Food Bank | San Diego County’s Leading Hunger-Relief Organization | James A. Floros

One of the things that set James A. Floros, President & CEO, Jacobs & Cushman San Diego Food Bank aside from other nonprofit CEOs is that he has always run a nonprofit like a business. “The efficiency and effectiveness that is required in the for-profit sector is even more important in the nonprofit sector because you are doing more with less, with less staff and less resources,” he explains. “Three to four weeks into the pandemic, I realized how well our organization was doing and I realized it was because of the work we had done in building an organization based on excellence.” They have an outstanding relationship with their donors, with media, elected officials, have top-notch financials, with 94 cents of every dollar going directly to our programs and services, and an amazing culture among the staff and volunteers.

FDA approves Alzheimer’s drug lecanemab amid security situations